Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Data Collection × Endocrine × Clear all

Phase

Status

Completed 4 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6 Tumor-Agnostic 4 Lymphoid 2 Head & Neck 2 Gynecologic 2 Genitourinary 2 Thoracic 1 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 NET 1 Endocrine 1 CNS 1 Breast 1

Conditions

Intestinal Neuroendocrine Tumor 1

Interventions

lutetium Lu 177 dotatate 14 Magnetic Resonance Spectroscopy 13 gallium Ga 68 dotatate 8 Specimen Handling 8 Everolimus 8 pembrolizumab 7 Cisplatin 7 cabozantinib 5 Etoposide 5 177Lu-octreotide, DOTA(0)-Tyr(3)- 5 lanreotide 4 Fluorodeoxyglucose F18 4 trametinib 3 surufatinib 3 olaparib 3 lenvatinib 3 fluorodopa F 18 3 dabrafenib 3 cemiplimab 3 X-Rays 3 Transurethral Resection of Prostate 3 Thyrotropin Alfa 3 Somatostatin 3 Nivolumab 3 Lutetium-177 3 Iodine-131 3 Injections 3 Drug Therapy 3 Cyclophosphamide 3 Carboplatin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06876532 2025-11-18

LUTIBI

Institut Claudius Regaud

Phase NA Recruiting

Intestinal Neuroendocrine Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡